Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests.